Skip to content
Med Pharma News

Med Pharma News

Your Daily Dose of Pharma News

  • About Med Pharma News
  • Contact Us
  • News
  • Privacy Policy
  • Terms and Conditions
  • Home
  • Industry Insights
  • Page 7

Category: Industry Insights

Get the latest industry insights and trends in the pharmaceutical sector with Med Pharma News. Stay informed about groundbreaking research, regulatory updates, and market analysis.

Graphic: anti-diabetic drugs market in India, capsule shapes showing 21 percent growth per IQVIA-based research and 16.1 percent per Pharmarack
  • Industry Insights

Anti-Diabetic Drugs Market Posts Strong Growth in India

Megan Wood1 month ago1 month ago011 mins

The anti-diabetic drugs market in India grew about 21% in September per one dataset and 16.1% per another. What drove it, including GLP-1 generics.

Read More
Graphic: Biopharma SHAKTI pilot of 25 clinical trial sites stepping toward the 1,000-site target
  • Industry Insights

Biopharma SHAKTI Gets a Strong Start With 25 Trial Sites

Megan Wood1 month ago1 month ago010 mins

Biopharma SHAKTI gets a 25-site clinical trial pilot as NIPER Raebareli and AstraZeneca India sign an MoU. What the pilot tests and what is undisclosed.

Read More
Graphic: Soufflé Therapeutics $135 million funding, RNA delivery arrows pointing from the liver toward the heart and muscle with a $135M Series B label
  • Industry Insights

Soufflé Therapeutics $135 Million Funding: Powerful Boost for RNA Drugs

Megan Wood1 month ago1 month ago011 mins

Soufflé Therapeutics $135 million funding backs RNA drugs for FSHD and heart failure. The treatments are experimental; no new human data were reported.

Read More
Graphic: Russia lab worker death timeline from 29 September to the WHO notice of 10 October 2026, with a question mark over the unknown cause
  • Industry Insights

Mystery Surrounds Young Worker’s Death at Russia Lab Studying Severe Diseases

Megan Wood1 month ago1 month ago013 mins

Russia lab worker death: a young employee of a plague institute died of pneumonia. WHO sees no spread, 5,500 tests found no pathogen, cause unknown.

Read More
Graphic: 108 dots showing New York measles cases, 92 highlighted as reported since 15 July across 18 counties
  • Industry Insights

New York Governor to Seek Federal Help on Measles Outbreak

Megan Wood1 month ago1 month ago014 mins

The New York measles outbreak has 108 cases as Governor Hochul seeks HHS and CDC help after Kennedy offered support. What is confirmed so far.

Read More
Graphic: magnifying glass over four tiles showing the HHS vaccine injury initiative moves, NIH clinic, CMS proposal, VAERS update and health records
  • Industry Insights

Kennedy Launches New Push on Vaccine Injuries: What HHS Revealed

Megan Wood1 month ago1 month ago014 mins

The vaccine injury initiative from HHS Secretary Kennedy adds an NIH clinic, VAERS changes and a CMS proposal. See what is known and what is not.

Read More
Graphic: City Therapeutics IPO at a valuation of up to $956.3 million, with a city skyline and a ticker banner for CTY
  • Industry Insights

City Therapeutics Eyes Valuation of Up to $956.3 Million in US IPO

Megan Wood1 month ago1 month ago012 mins

The City Therapeutics IPO targets a valuation of up to about $956 million at $17 to $19 a share. Terms, RNAi pipeline, financials and risks.

Read More
Graphic: about 2.01 million foreign patients in South Korea in 2025, beside a health checkup card listing blood tests and ultrasound
  • Industry Insights

Korea Medical Tourism Tops 2 Million as Health Checkups Boom

Megan Wood1 month ago1 month ago012 mins

Korea medical tourism drew about 2.01 million foreign patients in 2025, with blood tests and ultrasounds booming. See the data and the caveats.

Read More
Graphic: 69 Karnataka MLAs claimed Rs 7.47 crore in medical reimbursements between May 2023 and September 2026, RTI data
  • Industry Insights

69 Karnataka MLAs Claimed ₹7.47 Crore in Medical Bills, RTI Data Shows

Megan Wood1 month ago1 month ago011 mins

Karnataka MLAs medical bills: RTI data shows 69 MLAs claimed ₹7.47 crore from 2023 to 2026. Top claims, the rules and what is unknown.

Read More
  • 1
  • …
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 40

Categories

  • Healthcare IT (26)
  • Industry Insights (355)
  • Lifestyle and Wellness (24)
  • Medical Devices (45)
  • Pharmaceuticals (105)
  • Uncategorized (1)

Recent Posts

  • Teva Price-Fixing Settlement: 45 States Strike Deal in Generic Drug Collusion Case
  • Gedeon Richter Mayne Pharma Deal: A$604M Buys a US Women’s Health Platform
  • Lilly Stipple Bio Deal: Why Eli Lilly Is Betting Up to $5.9B on Tumor-Only Targets
  • Lilly Calytrix Acquisition: $1.5B Bet on a Blood Cancer Mutation
  • J&J Ollin Acquisition: $2.2B Bet on an Eye Drug Built to Beat Vabysmo
Digital Newspaper - Multipurpose News WordPress Theme 2026. Powered By BlazeThemes.